How much funding has Croivalve raised?

Croivalve has raised $55.4M in total funding, most recently a Extension Round.

Who are Croivalve's investors?

Croivalve's investors include Irrus Syndicate, MedTech Syndicate, HBAN MedTech Syndicate, Halo Business Angel Ne, European Innovation Council Fund, Broadview Ventures.

Where is Croivalve headquartered?

Croivalve is headquartered in Dublin, Ireland.

What industry is Croivalve in?

Croivalve operates in Biotech, Healthcare.

Croivalve

Treating Heart Valve Disease

Dublin, Ireland · Founded 2017 · $55.4M raised

Biotech

Healthcare

Headquarters: Dublin
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: croivalve.com
Total Funding: $55.4M
Last Round: $27.0M Extension RoundJun 2026
Rounds: 4

About

CroíValve is an early-stage medical device company developing a novel transcatheter device to repair the tricuspid valve. Its DUO™ System is a catheter-based coaptation device designed to treat tricuspid regurgitation by working in tandem with the native valve, preserving native valve function while restoring coaptation. The company has completed first-in-human implantations and is advancing clinical trials to address a significant unmet need in structural heart disease.

Summary

Croivalve is a Biotech company based in Dublin, Ireland, founded in 2017. It has raised $55.4M in total across 4 rounds, most recently a $27.0M Extension Round round in Jun 2026. Investors include Irrus Syndicate, MedTech Syndicate and HBAN MedTech Syndicate.